2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole

C178H107N17O6S — CID 160535603

IUPAC2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole
SMILESc1ccc(-c2ncc(-c3cccc(-c4cc(-c5nc6ccccc6s5)cc(-c5cc6cccnc6c6ncccc56)c4)c3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4cc(-c5nc6ccccc6o5)cc(-c5c6ccccc6cc6ccccc56)c4)cc3)o2)cc1.c1ccc(-n2c(-c3ccc(-c4cc(-c5c6ccccc6c(-c6nc7ccccc7o6)c6ccccc56)cc(-c5cc6cccnc6c6ncccc56)c4)cc3)nc3ccccc32)cc1.c1cncc(-c2nnc(-c3cccc(-c4cc(-c5c6ccccc6cc6ccccc56)cc(-c5nc6ccccc6o5)n4)c3)o2)c1
InChIInChI=1S/C58H35N5O.C41H25N3O2.C40H24N4OS.C39H23N5O2/c1-2-15-42(16-3-1)63-51-24-10-8-22-49(51)61-57(63)37-28-26-36(27-29-37)39-32-40(48-35-38-14-12-30-59-55(38)56-47(48)21-13-31-60-56)34-41(33-39)53-43-17-4-6-19-45(43)54(46-20-7-5-18-44(46)53)58-62-50-23-9-11-25-52(50)64-58;1-2-10-27(11-3-1)40-43-44-41(46-40)28-20-18-26(19-21-28)31-23-32(25-33(24-31)39-42-36-16-8-9-17-37(36)45-39)38-34-14-6-4-12-29(34)22-30-13-5-7-15-35(30)38;1-2-9-25(10-3-1)39-43-24-35(45-39)27-12-6-11-26(19-27)29-20-30(22-31(21-29)40-44-34-15-4-5-16-36(34)46-40)33-23-28-13-7-17-41-37(28)38-32(33)14-8-18-42-38;1-3-14-30-24(9-1)19-25-10-2-4-15-31(25)36(30)29-21-33(41-34(22-29)39-42-32-16-5-6-17-35(32)45-39)26-11-7-12-27(20-26)37-43-44-38(46-37)28-13-8-18-40-23-28/h1-35H;1-25H;1-24H;1-23H
InChIKeyQWCOPCMEKIHGNE-UHFFFAOYSA-N
MW2611.99 g/mol
LogP46.11
Rot. Bonds21

About 2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole

2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole (PubChem CID 160535603) has the molecular formula C178H107N17O6S and a molecular weight of 2611.99 g/mol. Its IUPAC name is 2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole.

Molecular Properties

Compound Name2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole
PubChem CID160535603
Molecular FormulaC178H107N17O6S
Molecular Weight2611.99 g/mol
Exact Mass2609.83
IUPAC Name2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole
SMILESc1ccc(-c2ncc(-c3cccc(-c4cc(-c5nc6ccccc6s5)cc(-c5cc6cccnc6c6ncccc56)c4)c3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4cc(-c5nc6ccccc6o5)cc(-c5c6ccccc6cc6ccccc56)c4)cc3)o2)cc1.c1ccc(-n2c(-c3ccc(-c4cc(-c5c6ccccc6c(-c6nc7ccccc7o6)c6ccccc56)cc(-c5cc6cccnc6c6ncccc56)c4)cc3)nc3ccccc32)cc1.c1cncc(-c2nnc(-c3cccc(-c4cc(-c5c6ccccc6cc6ccccc56)cc(-c5nc6ccccc6o5)n4)c3)o2)c1
InChIInChI=1S/C58H35N5O.C41H25N3O2.C40H24N4OS.C39H23N5O2/c1-2-15-42(16-3-1)63-51-24-10-8-22-49(51)61-57(63)37-28-26-36(27-29-37)39-32-40(48-35-38-14-12-30-59-55(38)56-47(48)21-13-31-60-56)34-41(33-39)53-43-17-4-6-19-45(43)54(46-20-7-5-18-44(46)53)58-62-50-23-9-11-25-52(50)64-58;1-2-10-27(11-3-1)40-43-44-41(46-40)28-20-18-26(19-21-28)31-23-32(25-33(24-31)39-42-36-16-8-9-17-37(36)45-39)38-34-14-6-4-12-29(34)22-30-13-5-7-15-35(30)38;1-2-9-25(10-3-1)39-43-24-35(45-39)27-12-6-11-26(19-27)29-20-30(22-31(21-29)40-44-34-15-4-5-16-36(34)46-40)33-23-28-13-7-17-41-37(28)38-32(33)14-8-18-42-38;1-3-14-30-24(9-1)19-25-10-2-4-15-31(25)36(30)29-21-33(41-34(22-29)39-42-32-16-5-6-17-35(32)45-39)26-11-7-12-27(20-26)37-43-44-38(46-37)28-13-8-18-40-23-28/h1-35H;1-25H;1-24H;1-23H
InChIKeyQWCOPCMEKIHGNE-UHFFFAOYSA-N
XLogP46.11
TPSA290.01 Ų
H-Bond Donors
H-Bond Acceptors24
Rotatable Bonds21
Heavy Atoms202
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002611.99
LogP ≤ 546.11
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole?
The IUPAC name of 2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole (CID 160535603) is 2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole.
What is the SMILES notation for 2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole?
The canonical SMILES for 2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole is c1ccc(-c2ncc(-c3cccc(-c4cc(-c5nc6ccccc6s5)cc(-c5cc6cccnc6c6ncccc56)c4)c3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4cc(-c5nc6ccccc6o5)cc(-c5c6ccccc6cc6ccccc56)c4)cc3)o2)cc1.c1ccc(-n2c(-c3ccc(-c4cc(-c5c6ccccc6c(-c6nc7ccccc7o6)c6ccccc56)cc(-c5cc6cccnc6c6ncccc56)c4)cc3)nc3ccccc32)cc1.c1cncc(-c2nnc(-c3cccc(-c4cc(-c5c6ccccc6cc6ccccc56)cc(-c5nc6ccccc6o5)n4)c3)o2)c1.
What is the InChIKey of 2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole?
The InChIKey is QWCOPCMEKIHGNE-UHFFFAOYSA-N. The full InChI is InChI=1S/C58H35N5O.C41H25N3O2.C40H24N4OS.C39H23N5O2/c1-2-15-42(16-3-1)63-51-24-10-8-22-49(51)61-57(63)37-28-26-36(27-29-37)39-32-40(48-35-38-14-12-30-59-55(38)56-47(48)21-13-31-60-56)34-41(33-39)53-43-17-4-6-19-45(43)54(46-20-7-5-18-44(46)53)58-62-50-23-9-11-25-52(50)64-58;1-2-10-27(11-3-1)40-43-44-41(46-40)28-20-18-26(19-21-28)31-23-32(25-33(24-31)39-42-36-16-8-9-17-37(36)45-39)38-34-14-6-4-12-29(34)22-30-13-5-7-15-35(30)38;1-2-9-25(10-3-1)39-43-24-35(45-39)27-12-6-11-26(19-27)29-20-30(22-31(21-29)40-44-34-15-4-5-16-36(34)46-40)33-23-28-13-7-17-41-37(28)38-32(33)14-8-18-42-38;1-3-14-30-24(9-1)19-25-10-2-4-15-31(25)36(30)29-21-33(41-34(22-29)39-42-32-16-5-6-17-35(32)45-39)26-11-7-12-27(20-26)37-43-44-38(46-37)28-13-8-18-40-23-28/h1-35H;1-25H;1-24H;1-23H.
What are the key properties of 2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole?
2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole has a molecular weight of 2611.99 g/mol, XLogP of 46.11, 21 rotatable bonds, 0 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-anthracen-9-yl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]-1,3-benzoxazole;2-[4-anthracen-9-yl-6-[3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)phenyl]-2-pyridinyl]-1,3-benzoxazole;5-[3-[3-(1,3-benzothiazol-2-yl)-5-(1,10-phenanthrolin-5-yl)phenyl]phenyl]-2-phenyl-1,3-oxazole;2-[10-[3-(1,10-phenanthrolin-5-yl)-5-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]anthracen-9-yl]-1,3-benzoxazole is sourced from PubChem (CID 160535603), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).